Groundbreaking research in cancer care is the cornerstone of ASCO’s Annual Meeting, and the deadline for submitting abstracts to be considered for presentation or publication at this year’s Meeting is fast approaching.
The submission deadline is February 5 at 11:59 PM (EST). Late-Breaking Abstracts for phase III trials for which no preliminary data are available at the time of the abstract submission deadline, but for which a preplanned analysis of the primary endpoint is scheduled before April 1, may be submitted.
“The ASCO Annual Meeting is a highly visible, international platform to present the most exciting advances in clinical cancer research,” said Douglas Yee, MD, Chair of the Annual Meeting’s Scientific Program Committee, and Director of the Masonic Cancer Center at the University of Minnesota. “Beyond the opportunity to present high-impact work, it also serves as a venue to seek feedback, advice, and develop collaborations.”
The Annual Meeting takes place May 31 to June 4 in Chicago. This year’s theme, Building Bridges to Conquer Cancer, emphasizes a growing need in oncology to build a bridge between scientific discoveries and new therapeutics and novel treatments for optimal patient outcomes.
Abstracts from all disciplines of oncology research and practice, from translational research to multidisciplinary care, may be submitted.
Submissions of superior quality will be selected by the ASCO Scientific Program Committee for presentation at the 2013 Meeting and for publication in the 2013 ASCO Annual Meeting Proceedings, a supplement to the Journal of Clinical Oncology. All abstract submissions must be sponsored by an ASCO member.
Notification in March and Beyond
In late March, each first author will receive a letter of notification via email regarding abstract selection. First authors of Late-Breaking Abstracts will receive a letter of notification in mid-April.
Abstracts that have been chosen for inclusion in the meeting will be released on ASCO.org on May 15, 2013, at 6:00 PM (EDT).
A Record Year
Last year, a record of more than 5,000 abstracts were submitted, representing the latest in clinical and translational science in the areas of cancer prevention, diagnosis, and treatment. More than 2,700 abstracts were presented or published, helping to set the standard for cancer care in the United States and around the world.
In conjunction with submitting an Annual Meeting abstract, oncology fellows and junior faculty may be eligible for several types of awards: a limited number of merit awards, the James B. Nachman ASCO Junior Faculty Award in Pediatric Oncology, and Oncology Trainee Travel Awards. In addition, oncologists from countries with limited resources are encouraged to submit an abstract in conjunction with the application process for the International Development and Education Award (IDEA).
These awards are offered through the Conquer Cancer Foundation of ASCO Grants and Awards Program. Award recipients will receive monetary support to attend the Annual Meeting, complimentary Meeting registration, access to the ASCO housing block, and the use of
ASCO’s travel agency.
For submission guidelines and to submit an abstract, visit asco.org/cfa. For more on the Annual Meeting, visit chicago2013.asco.org. ■
© 2013. American Society of Clinical Oncology. All rights reserved.